Amrubicin 1mg 1mg | Purity Not Available
Adooq Bioscience
Amrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageSearch Results
Salvianolic Acid B 50mg 50mg | Purity Not Available
Adooq Bioscience
Salvianolic Acid B is isolated and purified from the crude extract of Salvia miltiorrhiza.
More Information Supplier PageSalvianolic Acid B 5mg 5mg | Purity Not Available
Adooq Bioscience
Salvianolic Acid B is isolated and purified from the crude extract of Salvia miltiorrhiza.
More Information Supplier PageSalvianolic Acid B 25mg 25mg | Purity Not Available
Adooq Bioscience
Salvianolic Acid B is isolated and purified from the crude extract of Salvia miltiorrhiza.
More Information Supplier PageONX-0914 50mg 50mg | Purity Not Available
Adooq Bioscience
ONX 0914 is an immunoproteasome inhibitor with potential treatment applications in autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease and lupus. ONX 0914 was designed to be a potent inhibitor of the immunoproteasome with minimal cross-reactivity for the constitutive proteasome.
More Information Supplier PageONX-0914 5mg 5mg | Purity Not Available
Adooq Bioscience
ONX 0914 is an immunoproteasome inhibitor with potential treatment applications in autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease and lupus. ONX 0914 was designed to be a potent inhibitor of the immunoproteasome with minimal cross-reactivity for the constitutive proteasome.
More Information Supplier PageONX-0914 25mg 25mg | Purity Not Available
Adooq Bioscience
ONX 0914 is an immunoproteasome inhibitor with potential treatment applications in autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease and lupus. ONX 0914 was designed to be a potent inhibitor of the immunoproteasome with minimal cross-reactivity for the constitutive proteasome.
More Information Supplier PageONX-0914 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
ONX 0914 is an immunoproteasome inhibitor with potential treatment applications in autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease and lupus. ONX 0914 was designed to be a potent inhibitor of the immunoproteasome with minimal cross-reactivity for the constitutive proteasome.
More Information Supplier PageONX-0914 10mg 10mg | Purity Not Available
Adooq Bioscience
ONX 0914 is an immunoproteasome inhibitor with potential treatment applications in autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease and lupus. ONX 0914 was designed to be a potent inhibitor of the immunoproteasome with minimal cross-reactivity for the constitutive proteasome.
More Information Supplier PageT0901317 50mg 50mg | Purity Not Available
Adooq Bioscience
T0901317 is a potent, high affinity liver X receptor (LXR) agonist (EC50 ~ 50 nM, Kd values are 7 and 22 nM for LXR-?? and LXR-?? respectively).
More Information Supplier Page